Decision to acquire 60,000,000 shares (75.14% stake) of Hankook Union Pharmaceutical Co., Ltd. for KRW 30 billion (8.80% of equity)
Purpose: Expand production capacity and business through securing manufacturing facilities
Expected acquisition date: 2026-05-28
Acquisition method: Third-party allotment capital increase (cash acquisition)
Target company's financial condition is weak: Negative equity of -KRW 22.9 billion as of end-2025, net loss of -KRW 30.8 billion, auditor's opinion 'disclaimer'
The target has recorded consecutive net losses in 2024 and 2025, and is in a capital impairment state
KOSPI Filing Information
Filing: [Correction of Description] Decision on Acquisition of Stocks and Equity Securities of Other Corporations